Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRIM37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
USP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZDHHC21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KANSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF529 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00304 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on